Amy Feldman

In this week's edition of InnovationRx, we look at the spreading Ebola epidemic, the Midas list health investors, Lilly's trio of vaccine deals, and more.

In this week's edition of InnovationRx, we look at cancer breakthroughs from the ASCO conference, Clear's move into healthcare, Harrison.ai's U.S. expansion, and more.

Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it's in talks to raise $400 million more VC funding at a $3.4 billion valuation, Forbes has learned.

Collate Secures 95 Million Dollars to Accelerate AI Automation in Life Sciences Documentation Key Takeaways: • Collate raised 95 million dollars to scale AI systems that automate clinical, regulatory and quality documentation • The company’s momentum reflects growing demand for automation in complia

In this week's edition of InnovationRx, we look at SpaceX's hopes for healthcare, the AI drug discovery startup Lilly and Pfizer are betting on, the greatest living immigrants in healthcare and more.

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here

Cadence reached a $1.2 billion valuation by using AI to track seniors' chronic health conditions and improve their care. C

Scheduling doctor appointments is its own form of hell for both physicians and patients. Assort Health's AI fix helped it raise its third venture round in 14 months.

Assort Health cofounders Jeff Liu (left) and Jon WangAssort Health Scheduling doctor appointments is its own form of hell for both physicians and patients.

In this week's edition of InnovationRx, we look at AbbVie's new megadeal, an agentic AI startup saving Medicare $2 million a week, how new student loan rules could degrade healthcare and more.